Shen Shuai II recipe improves renal hypoxia to attenuate renal injury in 5/6 renal ablation/infarction rats and effect evaluation using blood oxygenation level-dependent functional magnetic resonance imaging

References

• Kalantar-Zadeh K, Jafar TH, Nitsch D, et al. Chronic kidney disease. Lancet. 2021;398(10302):786–802. doi: 10.1016/S0140-6736(21)00519-5.
   PubMed Web of Science ®Google Scholar
• Nastase MV, Zeng-Brouwers J, Wygrecka M, et al. Targeting renal fibrosis: mechanisms and drug delivery systems. Adv Drug Deliv Rev. 2018;129(10302):295–307. doi: 10.1016/j.addr.2017.12.019.
   PubMedGoogle Scholar
• Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol. 2006;17(1):17–25. doi: 10.1681/ASN.2005070757.
   PubMed Web of Science ®Google Scholar
• Evans RG, Gardiner BS, Smith DW, et al. Intrarenal oxygenation: unique challenges and the biophysical basis of homeostasis. Am J Physiol Renal Physiol. 2008;295(5):F1259–1270. doi: 10.1152/ajprenal.90230.2008.
   PubMed Web of Science ®Google Scholar
• Schödel J, Ratcliffe PJ. Mechanisms of hypoxia signalling: new implications for nephrology. Nat Rev Nephrol. 2019;15(10):641–659. doi: 10.1038/s41581-019-0182-z.
   PubMed Web of Science ®Google Scholar
• Shen Y-L, Wang S-J, Rahman K, et al. Chinese herbal formulas and renal fibrosis: an overview. Curr Pharm Des. 2018;24(24):2774–2781. doi: 10.2174/1381612824666180829103355.
   PubMed Web of Science ®Google Scholar
• Yang L, Wang M, Zhou Y, et al. Shen Shuai II recipe attenuates renal interstitial fibrosis by improving hypoxia via the IL-1beta/c-Myc pathway. Evid Based Complement Alternat Med. 2021;2021:5539584.
   PubMed Web of Science ®Google Scholar
• Wang M, Wang L, Zhou Y, et al. Shen Shuai recipe attenuates renal fibrosis in chronic kidney disease by improving hypoxia-induced the imbalance of mitochondrial dynamics via PGC-1alpha activation. Phytomedicine. 2022;98:153947. doi: 10.1016/j.phymed.2022.153947.
   PubMed Web of Science ®Google Scholar
• Wang M, Yang J, Zhou Y, et al. ShenShuai II recipe attenuates apoptosis and renal fibrosis in chronic kidney disease by increasing renal blood flow and improving oxygen consumption. Evid Based Complement Alternat Med. 2018;2018:7602962–7602968. doi: 10.1155/2018/7602962.
   PubMed Web of Science ®Google Scholar
• Jiang K, Ferguson CM, Lerman LO. Noninvasive assessment of renal fibrosis by magnetic resonance imaging and ultrasound techniques. Transl Res. 2019;209:105–120. doi: 10.1016/j.trsl.2019.02.009.
   PubMed Web of Science ®Google Scholar
• Pruijm M, Mendichovszky IA, Liss P, et al. Renal blood oxygenation level-dependent magnetic resonance imaging to measure renal tissue oxygenation: a statement paper and systematic review. Nephrol Dial Transplant. 2018;33(suppl_2):ii22–ii28. doi: 10.1093/ndt/gfy243.
   PubMedGoogle Scholar
• Zhang L, Chen S, Liu Y, et al. P-selectin blockade ameliorates lupus nephritis in MRL/lpr mice through improving renal hypoxia and evaluation using BOLD-MRI. J Transl Med. 2020;18(1):116. doi: 10.1186/s12967-020-02284-1.
   PubMed Web of Science ®Google Scholar
• Wang R, Lin Z, Yang X, et al. Noninvasive evaluation of renal hypoxia by multiparametric functional MRI in early diabetic kidney disease. J Magn Reson Imaging. 2022;55(2):518–527. doi: 10.1002/jmri.27814.
   PubMed Web of Science ®Google Scholar
• Sørensen SS, Gullaksen S, Vernstrøm L, et al. Evaluation of renal oxygenation by BOLD-MRI in high-risk patients with type 2 diabetes and matched controls. Nephrol Dial Transplant. 2023;38(3):691–699. doi: 10.1093/ndt/gfac186.
   PubMed Web of Science ®Google Scholar
• Prasad PV, Li LP, Hack B, et al. Quantitative blood oxygenation level dependent magnetic resonance imaging for estimating intra-renal oxygen availability demonstrates kidneys are hypoxemic in human CKD. Kidney Int Rep. 2023;8(5):1057–1067. doi: 10.1016/j.ekir.2023.02.1092.
   PubMed Web of Science ®Google Scholar
• Yang J, Yang S, Xu Y, et al. Evaluation of renal oxygenation and hemodynamics in patients with chronic kidney disease by blood oxygenation level-dependent magnetic resonance imaging and intrarenal doppler ultrasonography. Nephron. 2021;145(6):653–663. doi: 10.1159/000516637.
   PubMed Web of Science ®Google Scholar
• Xu Y, Yang J, Lu F, et al. Correlation of renal oxygenation with renal function in chronic kidney disease: a preliminary prospective study. Kidney Blood Press Res. 2023;48(1):175–185. doi: 10.1159/000529165.
   PubMed Web of Science ®Google Scholar
• Wang M, Yang J, Wang C. Shen Shuai II recipe attenuates apoptosis in 5/6 renal ablation/infarction rats by inhibiting p53 and the mitochondrial pathway of apoptosis. Oxid Med Cell Longev. 2020;2020:7083575.
   PubMed Web of Science ®Google Scholar
• Deng A, Tang T, Singh P, et al. Regulation of oxygen utilization by angiotensin II in chronic kidney disease. Kidney Int. 2009;75(2):197–204. doi: 10.1038/ki.2008.481.
   PubMed Web of Science ®Google Scholar
• Wang M, Yang L, Yang J, et al. Shen Shuai II recipe attenuates renal injury and fibrosis in chronic kidney disease by regulating NLRP3 inflammasome and Sirt1/Smad3 deacetylation pathway. BMC Complement Altern Med. 2019;19(1):107. doi: 10.1186/s12906-019-2524-6.
   PubMedGoogle Scholar
• Stanko P, Baka T, Repova K, et al. Ivabradine ameliorates kidney fibrosis in L-NAME-Induced hypertension. Front Med (Lausanne). 2020;7:325. doi: 10.3389/fmed.2020.00325.
   PubMed Web of Science ®Google Scholar
• Obrador GT, Levin A. CKD hotspots: challenges and areas of opportunity. Semin Nephrol. 2019;39(3):308–314. doi: 10.1016/j.semnephrol.2019.02.009.
   PubMed Web of Science ®Google Scholar
• Hirakawa Y, Tanaka T, Nangaku M. Renal hypoxia in CKD; pathophysiology and detecting methods. Front Physiol. 2017;8:99. doi: 10.3389/fphys.2017.00099.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Menon MC, Deng Y, et al. Recent advances in traditional chinese medicine for kidney disease. Am J Kidney Dis. 2015;66(3):513–522. doi: 10.1053/j.ajkd.2015.04.013.
   PubMed Web of Science ®Google Scholar
• Zhang M, Feng L, Gu J, et al. The attenuation of moutan cortex on oxidative stress for renal injury in AGEs-induced mesangial cell dysfunction and streptozotocin-induced diabetic nephropathy rats. Oxid Med Cell Longev. 2014;2014:463815–463813. doi: 10.1155/2014/463815.
   PubMed Web of Science ®Google Scholar
• Shao M, Ye C, Bayliss G, et al. New insights into the effects of individual chinese herbal medicines on chronic kidney disease. Front Pharmacol. 2021;12:774414. doi: 10.3389/fphar.2021.774414.
   PubMed Web of Science ®Google Scholar
• Wang L, Feng X, Ye C, et al. Shen shuai II recipe inhibits hypoxia-induced glycolysis by preserving mitochondrial dynamics to attenuate kidney fibrosis. J Ethnopharmacol. 2023;308:116271. doi: 10.1016/j.jep.2023.116271.
   PubMed Web of Science ®Google Scholar
• Wang M, Wang L, Zhou L, et al. Shen-Shuai-II-recipe inhibits tubular inflammation by PPARalpha-mediated fatty acid oxidation to attenuate fibroblast activation in fibrotic kidneys. Phytomedicine. 2024;126:155450. doi: 10.1016/j.phymed.2024.155450.
   PubMedGoogle Scholar
• Li J, Zhang C, He W, et al. Coordination-driven assembly of catechol-modified chitosan for the kidney-specific delivery of salvianolic acid B to treat renal fibrosis. Biomater Sci. 2017;6(1):179–188. doi: 10.1039/c7bm00811b.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yu F, Li A, et al. The progress and prospect of natural components in rhubarb (rheum ribes L.) in the treatment of renal fibrosis. Front Pharmacol. 2022;13:919967. doi: 10.3389/fphar.2022.919967.
   PubMed Web of Science ®Google Scholar
• Yang G, Zhao Z, Zhang X, et al. Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the notch/snail pathway in diabetic nephropathy model KKAy mice. Drug Des Devel Ther. 2017;11:1065–1079. doi: 10.2147/DDDT.S124971.
   PubMed Web of Science ®Google Scholar
• Akhter J, Khan J, Baghel M, et al. NLRP3 inflammasome in rosmarinic acid-afforded attenuation of acute kidney injury in mice. Sci Rep. 2022;12(1):1313. doi: 10.1038/s41598-022-04785-z.
   PubMed Web of Science ®Google Scholar
• Wang M, Wang L, Zhou Y, et al. Icariin attenuates renal fibrosis in chronic kidney disease by inhibiting interleukin-1beta/transforming growth factor-beta-mediated activation of renal fibroblasts. Phytother Res. 2021;35(11):6204–6215. doi: 10.1002/ptr.7256.
   PubMed Web of Science ®Google Scholar
• Sharma S, Iqubal A, Khan V, et al. Icariin ameliorates oxidative stress-induced inflammation, apoptosis, and heart failure in isoproterenol-challenged wistar rats. Iran J Basic Med Sci. 2023;26(5):517–525.
   PubMed Web of Science ®Google Scholar
• Pruijm M, Milani B, Burnier M. Blood oxygenation level-dependent MRI to assess renal oxygenation in renal diseases: progresses and challenges. Front Physiol. 2016;7:667. doi: 10.3389/fphys.2016.00667.
   PubMed Web of Science ®Google Scholar
• Li LP, Ji L, Lindsay S, et al. Evaluation of intrarenal oxygenation in mice by BOLD MRI on a 3.0T human whole-body scanner. J Magn Reson Imaging. 2007;25(3):635–638. doi: 10.1002/jmri.20841.
   PubMed Web of Science ®Google Scholar
• Ngo JP, Kar S, Kett MM, et al. Vascular geometry and oxygen diffusion in the vicinity of artery-vein pairs in the kidney. Am J Physiol Renal Physiol. 2014;307(10):F1111–1122. doi: 10.1152/ajprenal.00382.2014.
   PubMed Web of Science ®Google Scholar
• Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med. 2011;364(7):656–665. doi: 10.1056/NEJMra0910283.
   PubMed Web of Science ®Google Scholar
• Nuhu F, Bhandari S. Oxidative stress and cardiovascular complications in chronic kidney disease, the impact of anaemia. Pharmaceuticals (Basel). 2018;11(4):103. doi: 10.3390/ph11040103.
   PubMedGoogle Scholar
• Tanaka T, Nangaku M. Angiogenesis and hypoxia in the kidney. Nat Rev Nephrol. 2013;9(4):211–222. doi: 10.1038/nrneph.2013.35.
   PubMed Web of Science ®Google Scholar
• Hill P, Shukla D, Tran MG, et al. Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury. J Am Soc Nephrol. 2008;19(1):39–46. doi: 10.1681/ASN.2006090998.
   PubMed Web of Science ®Google Scholar
• Singh AK, Kolligundla LP, Francis J, et al. Detrimental effects of hypoxia on glomerular podocytes. J Physiol Biochem. 2021;77(2):193–203. doi: 10.1007/s13105-021-00788-y.
   PubMed Web of Science ®Google Scholar